Pharmaceuticals News

Supinoxin™ and RX-3117 Phase I clinical trials expected to be completed in the first half of 2015 Patient enrollment is ongoing for Phase IIa Archexin® trial in treatment of...

Co-founder and CSO Dr. Justin Hanes to deliver keynote presentation President & CEO Michael O'Rourke to speak on panel BALTIMORE, March 17, 2015 (GLOBE NEWSWIRE) -- GrayBug Inc., a...

REDWOOD CITY, Calif., March 17, 2015 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS), a leading pure-play, global biosimilars company with late-stage clinical products, today announced...

MADISON, Wis., March 17, 2015 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB), a clinical stage biopharmaceutical company developing innovative agents for the detection and treatment of...

LEXINGTON, Mass., March 17, 2015 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to...

HAMPTON, N.J., March 17, 2015 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (Nasdaq:CLDX) announced today that it has entered into a clinical trial collaboration with Roche to evaluate the safety,...

SAN CARLOS, Calif., March 17, 2015 (GLOBE NEWSWIRE) -- Cellerant Therapeutics Inc., a biotechnology company developing novel hematopoietic (blood forming) stem cell-based cellular and antibody...

SALT LAKE CITY, March 17, 2015 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today announced an expansion of the Company's collaboration with BioMarin Pharmaceutical Inc. Under the expanded...

CANTON, Mass., March 17, 2015 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. today announced a poster presentation of the Company's completed Phase III clinical trial that evaluated the efficacy...

HAMBURG, Germany, March 17, 2015 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt Stock Exchange:EVT) (TecDAX) (ISIN:DE0005664809) will report its financial results for 2014 on Tuesday, 24 March 2015. The...